drugset / Trial / NCT06275633

Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD

NCT06275633

NaSingle-groupOpen-labelDiagnostic

Summary

In this project, patients with Parkinson's Disease (PD) will be characterized by measuring cognitive and motor function and relation to effect of Levodopa. Participants will be patients with Parkinson's Disease and healthy controls. It will be investigated if there is a difference between patients with a good measured Levodopa response and with a poor measured response.

Timeline

Start
2019-03-19
Primary completion
2021-12-03
Completion
2023-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule 200 mg